In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintidesemaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide Wikipedia #Eloralintide vs #Cagrilintide Which #Amylin Agonist is Better? CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure Nature Metabolism Characterization of 0839 A tool compound for pre clinical mode of action studies of amylin analogues such as cagrilintide ScienceDirect